Blockbuster AbbVie drug Humira to face competition in US for first time
Amgen to launch ‘biosimilar’ version of medicine that has generated $200bn in sales since launch (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 31, 2023 Category: Pharmaceuticals Source Type: news

Wellstar Health ’s Stephen Vault: ‘Remain in a state of continual learning’
The 2023 Leaders in Corporate Citizenship honorees will be celebrated at an event on Feb. 16. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 31, 2023 Category: Pharmaceuticals Authors: Jessica Saunders Source Type: news

Kaleida Health/UBMD surgery center will come with $25M price tag
The 40 surgeons who plan to operate at the Kaleida Health/UBMD site expect to do more than 11,000 procedures annually, making it one of the top five largest local sites for volume. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 31, 2023 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Pfizer could offload Durham facility as part of R & D strategy shift
Pfizer is rethinking its strategy for early-stage drug development for rare diseases, meaning a large facility in Durham could soon hit the market. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 31, 2023 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news

Pharma Companies: A Conglomerate Of Monopolies
To understand why drug prices are rising rapidly while drug innovation lags, it ’s helpful to look at how biopharmaceutical research and development (R&D) has changed. This evolution has led to a conglomerate of monopolies. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 31, 2023 Category: Pharmaceuticals Authors: Robert Pearl, M.D., Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma Source Type: news

AMJEVITA ™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
Amgen (NASDAQ:AMGN) today announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira®* (adalimumab), is now available in the United States. AMJEVITA was the first biosimilar to Humira approved by the U.S. Food and Drug Administration (FDA), in 2016.(1,2) (Source: World Pharma News)
Source: World Pharma News - January 31, 2023 Category: Pharmaceuticals Tags: Featured Amgen Business and Industry Source Type: news

Covid Public Health Emergencies Will End May 11, White House Says
The end of the Covid-19 emergency is likely to end wide access to free vaccines and tests. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 31, 2023 Category: Pharmaceuticals Authors: Siladitya Ray, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news

Five questions with Dr. Naoto Ueno, UH Cancer Center's new director
PBN chatted with Dr. Naoto Ueno recently about his transition, hiring and funding goals for the UH Cancer Center. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 31, 2023 Category: Pharmaceuticals Authors: Kelsey Kukaua Medeiros Source Type: news

Monthly News Roundup - January 2023
Oral Rybelsus Now a First-Line Option in Treatment of Type 2 Diabetes  In January, the U.S. Food and Drug Administration (FDA) cleared Novo Nordisk’s once-daily Rybelsus (semaglutide) oral tablets as a first-line treatment to improve... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2023 Category: Pharmaceuticals Source Type: news

Domestic pharmaceutical market to reach $130 bn by 2030: Eco Survey
"The Indian Pharmaceutical industry plays a prominent role in the global pharmaceutical industry," it said adding, India is ranked 3rd worldwide in the production of pharma products by volume and 14th by value. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 31, 2023 Category: Pharmaceuticals Source Type: news

Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tablets
The tentative approval by the United States Food and Drug Administration (USFDA) has been granted under the President's emergency plan for AIDS relief (PEPFAR), Lupin said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 31, 2023 Category: Pharmaceuticals Source Type: news

NCPDP Announces Admiral Brett Giroir, M.D., as Opening Keynote Speaker...
16th HHS Assistant Secretary for Health, Dr. Giroir, Will Engage and Inspire Conference Goers in a Powerful Call to Action to Close Gaps in Healthcare.(PRWeb January 31, 2023)Read the full story at https://www.prweb.com/releases/ncpdp_announces_admiral_brett_giroir_m_d_as_opening_keynote_speaker_for_its_2023_annual_technology_business_conference/prweb19139784.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 31, 2023 Category: Pharmaceuticals Source Type: news

University of Medicine and Health Sciences Presents “Medical Specialty...
Discussion Focused on Career Opportunities For Future Doctors(PRWeb January 31, 2023)Read the full story at https://www.prweb.com/releases/university_of_medicine_and_health_sciences_presents_medical_specialty_spotlight_what_is_an_anesthesiologist/prweb19143268.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 31, 2023 Category: Pharmaceuticals Source Type: news

Mortality Down With Surgery for Stenosis With, Without Spondylolisthesis
MONDAY, Jan. 30, 2023 -- For patients with stenosis with or without spondylolisthesis, surgical treatment is associated with significantly lower mortality and total medical payments at two years compared with nonsurgical treatment, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2023 Category: Pharmaceuticals Source Type: news

Long COVID Explored in University Settings
MONDAY, Jan. 30, 2023 -- In an article published online Jan. 26 in Emerging Infectious Disease, a publication of the U.S. Centers for Disease Control and Prevention, factors associated with long COVID are explored in a sample of COVID-19 cases among... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2023 Category: Pharmaceuticals Source Type: news